Codario Type 2 Diabetes, Pre-Diabetes, and the Metabolic Syndrome

1. Auflage 2007
ISBN: 978-1-59259-932-5
Verlag: Humana Press
Format: PDF
Kopierschutz: 1 - PDF Watermark

E-Book, Englisch, 248 Seiten, eBook

Reihe: Current Clinical Practice

Type 2 Diabetes, Pre-Diabetes, and the Metabolic Syndrome: The Primary Care Guide to Diagnosis and Management is an important addition to the literature for primary care phy- cians. It covers concisely and with attention to clinical relevance the full spectrum of insulin resistance and diabetes. This book gives a practical, no-nonsense approach to understanding the basic pathophysiology of diabetes and the metabolic syndrome, an approach to treatment with oral agents and insulin, and an approach to risk factor management. By putting all this information in one readable text, Dr. Codario provides a service to us all, facilitating the understanding of a body of knowledge that cannot be obtained through any attempt to read portions of much larger textbooks in the field. This textbook will serve as a resource for medical students, residents in family medicine and internal medicine, and attending physicians who wish to update and improve their kno- edge in the field of diabetes and the newly emerging science of the metabolic syndrome. In addition, it allows attending physicians the opportunity to obtain Continuing Medical E- cation credits while performing self-directed learning. At the end of reading Type 2 Dia- tes, Pre-Diabetes, and the Metabolic Syndrome: The Primary Care Guide to Diagnosis and Management, the physician should feel comfortable and confident that they have acquired a solid understanding of the latest information in the field, and by so doing, should be better able to take excellent care of patients with diabetes and the metabolic syndrome.

Zielgruppe

Professional/practitioner

Autoren/Hrsg.

Codario, Ronald A.

Inhaltsverzeichnis

Pathophysiology of Type 2 Diabetes.- Guidelines and Classifications.- Exercise.- Nutrition.- Obesity and the Metabolic Syndrome.- Oral Agents for Type 2 Diabetes.- Insulin Use.- Macrovascular Disease.- Microvascular Disease.- Diabetic Dyslipidemia.- Hypertension in Patients With Diabetes.- Glycemic Control.- Risk Reduction in Patients With Diabetes.